-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Immunogenicity Assay Platform Technical Characteristics
Author:
InnoModels
Release time:
2024-04-28
As a bright pearl in the field of drug discovery and development, InnoModels' immunogenicity testing platform has attracted the attention of many research institutions and enterprises with its unique advantages and comprehensive service capabilities. With advanced testing technology and equipment, combined with an experienced and skilled team, the platform provides professional immunogenicity research services for drug R&D, escorting drug development.
1. Ensure the accuracy and reliability of experimental results
InnoModels' immunogenicity testing platform adopts advanced testing technology and equipment to ensure the accuracy and reliability of experimental results. The platform introduces a series of international advanced testing instruments, such as flow cytometer, enzyme labeling instrument, immunohistochemistry instrument, etc., to provide accurate data support for the experiments. At the same time, the platform strictly follows the national and international standards, and has formulated a set of perfect experimental operation procedures and quality control system to ensure that each experimental link can reach the best state, so as to provide customers with the most accurate experimental results.

2、Experienced and skilled team
InnoModels Biotechnology immunogenicity testing platform has an experienced and skilled team with solid theoretical foundation and rich practical experience. They not only have profound attainments in the field of immunogenicity research, but also can keep up with the international cutting-edge technology and constantly update their knowledge to provide customers with the best quality services. This team always focuses on the customer, in-depth understanding of customer needs, and customized experimental solutions to ensure the practicality and operability of the experimental results.
3、Providing comprehensive immunogenicity assessment services
InnoModels' immunogenicity testing platform is capable of providing comprehensive immunogenicity assessment services, including cellular immunity, humoral immunity and ultrasensitive reaction research. The platform has a complete experimental technology system and can provide customers with one-stop services from sample processing, experimental design, data analysis to result interpretation. At the same time, the platform can also provide personalized experimental solutions according to the needs of customers to meet the different needs of customers in the process of drug development.
All in all, with its advanced technical equipment, professional team and comprehensive service capability, InnoModels' immunogenicity testing platform provides strong support for the drug discovery and development field. In the future, InnoModels Biotechnology will continue to adhere to the concept of "professionalism, innovation, service and win-win", continuously optimize and improve the platform services, provide more customers with better and more efficient immunogenicity testing services, and help the global drug discovery and development business to achieve even more brilliant achievements.
In this ever-changing technological era, InnoModels' immunogenicity testing platform will keep up with international cutting-edge technologies, actively expand new research fields, and provide more diversified and higher-quality testing services for drug discovery and development. At the same time, the platform will also strengthen cooperation and communication with domestic and foreign research institutions and enterprises to jointly promote technological progress and industrial upgrading in the field of drug R&D.
In the future development, InnoModels Biotechnology immunogenicity testing platform will continue to play its important role in the field of drug R&D and provide strong technical support for more research projects and enterprises. It is believed that with the efforts of InnoModels Biotechnology, drug R&D will achieve even more impressive results and contribute more to the development of human health.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd